JOSÉ LUIS
RODRÍGUEZ PERALTO
Catedrático de universidad
Universitat de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat de Barcelona (11)
2022
-
Activity and safety of topical pimecrolimus in patients with early stage mycosis fungoides (PimTo-MF): a single-arm, multicentre, phase 2 trial
The Lancet Haematology, Vol. 9, Núm. 6, pp. e425-e433
2021
-
3D-printed portable robotic mobile microscope for remote diagnosis of global health diseases
Electronics (Switzerland), Vol. 10, Núm. 19
-
Differences in cutaneous melanoma survival between the 7th and 8th edition of the American Joint Committee on Cancer (AJCC). A multicentric population-based study
European Journal of Cancer, Vol. 145, pp. 29-37
2020
-
Frequency and Clinicopathological Profile Associated with Braf Mutations in Patients with Advanced Melanoma in Spain
Translational Oncology, Vol. 13, Núm. 6
2019
-
Multiple immunofluorescence assay identifies upregulation of Active β-catenin in prostate cancer
BMC Research Notes, Vol. 12, Núm. 1
2018
-
Dermatomyositis panniculitis: a clinicopathological and immunohistochemical study of 18 cases
Journal of the European Academy of Dermatology and Venereology, Vol. 32, Núm. 8, pp. 1352-1359
-
Intermittent hypoxia is associated with high hypoxia inducible factor-1α but not high vascular endothelial growth factor cell expression in tumors of cutaneous melanoma patients
Frontiers in Neurology, Vol. 9, Núm. APR
-
Sleep-Disordered Breathing Is Independently Associated With Increased Aggressiveness of Cutaneous Melanoma: A Multicenter Observational Study in 443 Patients
Chest, Vol. 154, Núm. 6, pp. 1348-1358
2017
-
A prospective multicenter cohort study of cutaneous melanoma: Clinical staging and potential associations with HIF-1α and VEGF expressions
Melanoma Research, Vol. 27, Núm. 6, pp. 558-564
2015
-
Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and sézary syndrome: Effect of specific prognostic markers on survival and development of a prognostic model
Journal of Clinical Oncology, Vol. 33, Núm. 32, pp. 3766-3773
-
Spanish Multidisciplinary Melanoma Group (GEM) guidelines for the management of patients with advanced melanoma
European Journal of Dermatology, Vol. 25, Núm. 5, pp. 392-403